IMV Inc IMVIQ

IMV to Participate in Adelaide Capital’s Virtual COVID & Hea

[Breakthorough1]

IMV Inc. (Nasdaq: IMV; TSX: IMV) a clinical-stage biopharmaceutical company, today announced that Companys management will be participating inAdelaide Capitals Virtual COVID & Healthcare Mini Conferenceon April 23, 2020 from 12pm-5pm ET. The conference will showcase the role Canadian companies are playing to help fight the coronavirus pandemic. IMV will present its plans around its DPX-COVID-19 candidate currently in development with well-respected Canadian experts. The conference will consist of 20-minute presentations followed by a panel discussing some of the key issues involved in the crisis today and a featured keynote by Next Edge Capitals Eden Rahim entitled Signal from the Noise: A compass to finding COVID19 investment opportunities. In participating in this conference, IMV will be supporting theHandSan Project. Please RSVP for this event directly throughthe link provided by Adelaide Capital.IMV is scheduled to make its virtual presentation at 2:20 pm. Eastern Time and will then take part in the panel discussion scheduled later that day at 3:40 pm. A copy of IMVs presentation will be available in theEvents, Webcasts and Presentationsof the investors section of the IMV website. IMV will also continue to provide updates on the development of DPX-COVID-19, and is working on a dedicated DPX-COVID-19 page on itswebsite.